Literature DB >> 12799371

ADP-ribosylation factor-dependent phospholipase D activation by the M3 muscarinic receptor.

Rory Mitchell1, Derek N Robertson, Pamela J Holland, Daniel Collins, Eve M Lutz, Melanie S Johnson.   

Abstract

G protein-coupled receptors can potentially activate phospholipase D (PLD) by a number of routes. We show here that the native M3 muscarinic receptor in 1321N1 cells and an epitope-tagged M3 receptor expressed in COS7 cells substantially utilize an ADP-ribosylation factor (ARF)-dependent route of PLD activation. This pathway is activated at the plasma membrane but appears to be largely independent of G, phospholipase C, Ca2+ q/11, protein kinase C, tyrosine kinases, and phosphatidyl inositol 3-kinase. We report instead that it involves physical association of ARF with the M3 receptor as demonstrated by co-immunoprecipitation and by in vitro interaction with a glutathione S-transferase fusion protein of the receptor's third intracellular loop domain. Experiments with mutant constructs of ARF1/6 and PLD1/2 indicate that the M3 receptor displays a major ARF1-dependent route of PLD1 activation with an additional ARF6-dependent pathway to PLD1 or PLD2. Examples of other G protein-coupled receptors assessed in comparison display alternative pathways of protein kinase C- or ARF6-dependent activation of PLD2.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12799371     DOI: 10.1074/jbc.M305825200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Regulation of M₃ muscarinic receptor expression and function by transmembrane protein 147.

Authors:  Erica Rosemond; Mario Rossi; Sara M McMillin; Marco Scarselli; Julie G Donaldson; Jürgen Wess
Journal:  Mol Pharmacol       Date:  2010-11-05       Impact factor: 4.436

2.  ArfGAP1 restricts Mycobacterium tuberculosis entry by controlling the actin cytoskeleton.

Authors:  Ok-Ryul Song; Christophe J Queval; Raffaella Iantomasi; Vincent Delorme; Sabrina Marion; Romain Veyron-Churlet; Elisabeth Werkmeister; Michka Popoff; Isabelle Ricard; Samuel Jouny; Nathalie Deboosere; Frank Lafont; Alain Baulard; Edouard Yeramian; Laurent Marsollier; Eik Hoffmann; Priscille Brodin
Journal:  EMBO Rep       Date:  2017-11-15       Impact factor: 8.807

3.  Role of curcumin in PLD activation by Arf6-cytohesin1 signaling axis in U46619-stimulated pulmonary artery smooth muscle cells.

Authors:  Sajal Chakraborti; Jaganmay Sarkar; Rajabrata Bhuyan; Tapati Chakraborti
Journal:  Mol Cell Biochem       Date:  2017-08-05       Impact factor: 3.396

Review 4.  Protein kinase D2: a versatile player in cancer biology.

Authors:  Ninel Azoitei; Mathias Cobbaut; Alexander Becher; Johan Van Lint; Thomas Seufferlein
Journal:  Oncogene       Date:  2017-12-20       Impact factor: 9.867

5.  ADP-ribosylation factor 1 controls the activation of the phosphatidylinositol 3-kinase pathway to regulate epidermal growth factor-dependent growth and migration of breast cancer cells.

Authors:  Pierre-Luc Boulay; Mathieu Cotton; Paul Melançon; Audrey Claing
Journal:  J Biol Chem       Date:  2008-11-06       Impact factor: 5.157

6.  Role of phospholipase D in parathyroid hormone type 1 receptor signaling and trafficking.

Authors:  José Luis Garrido; David Wheeler; Luis Leiva Vega; Peter A Friedman; Guillermo Romero
Journal:  Mol Endocrinol       Date:  2009-10-16

7.  G-protein-coupled receptor interaction with small GTPases.

Authors:  Chunmin Dong; Guangyu Wu
Journal:  Methods Enzymol       Date:  2013       Impact factor: 1.600

8.  ADP-ribosylation factors modulate the cell surface transport of G protein-coupled receptors.

Authors:  Chunmin Dong; Xiaoping Zhang; Fuguo Zhou; Huijuan Dou; Matthew T Duvernay; Ping Zhang; Guangyu Wu
Journal:  J Pharmacol Exp Ther       Date:  2010-01-21       Impact factor: 4.030

9.  Neurotrophic actions of PACAP-38 and LIF on human neuroblastoma SH-SY5Y cells.

Authors:  T K Monaghan; C Pou; C J MacKenzie; R Plevin; E M Lutz
Journal:  J Mol Neurosci       Date:  2008-05-28       Impact factor: 3.444

Review 10.  Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancer.

Authors:  Ronald C Bruntz; Craig W Lindsley; H Alex Brown
Journal:  Pharmacol Rev       Date:  2014-10       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.